Bendamustine Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-251

This is a drug label for a medicine called "Bendamustine Hydrochloride" for intravenous injection, with 100 mg/vial. The label provides instructions on usage, dosage, storage, and transportation. It also mentions a discard procedure for unused portions.*

This is a medication called Bendamustine Hydrochloride which comes in a single-dose vial containing 100 mg of the drug and 170 mg of Mannitol. It is meant for intravenous infusion only and requires reconstitution and dilution with sterile water. The recommended dosage information can be found in the insert. After reconstitution, it should immediately be transferred to 0.9% Sodium Chloride Injection or 2.5% dextrose/0.45% sodium chloride injection. The medication should be stored at controlled room temperature and protected from light. The unused portion should be discarded. The product is manufactured by Accord Healthcare Inc. and Intas Pharmaceuticals Limited, with the NDC code of 16729-251-05. The label includes additional technical information such as Lot and EXP number and manufacturing license number.*

This appears to be an information sheet for a drug called Bendamustine Hydrochloride for injection, USP. The sheet provides details such as the drug's name, dosage, instructions for use (intravenous), and other relevant information such as lot numbers and expiration dates. There is also information about the packaging, including the size of the vial and the product code.*

This is a medication that contains Bendamustine Hydrochloride and Manitol. It is a sterile, single-dose injection that should be prepared and stored under recommended conditions. The medication should be protected from light and stored at a temperature of up to 25°C. Dosage information can be found in the insert provided. It is manufactured by Accord Healthcare and Inas Pharmaceuticas Limied. Batch coding and data matrix should be kept in a blank and varnish-free area of 18 x 21mm.*